Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic Study of Reformulated Levulan Kerastick in Actinic Keratosis
NCT07729579Phase 1Recruiting
- Sponsor
- Sun Pharma
- Start
- Aug 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of aminolevulinic acid in actinic keratosis (AK), sponsored by Sun Pharma. Primary endpoint: Plasma concentrations of ALA and PpIX at 48 hours. Started Aug 2026; status: recruiting.
02
Drugs
aminolevulinic acid
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT07729579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07729579.